ArticleJBMR plus2023

Cardiovascular Safety in Postmenopausal Women and Men With Osteoporosis Treated With Denosumab and Zoledronic Acid: A Post-Authorization Safety Study.

Leslie Spangler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.